A detailed history of Manhattan West Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Manhattan West Asset Management, LLC holds 1,613 shares of LLY stock, worth $1.27 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
1,613
Previous 1,557 3.6%
Holding current value
$1.27 Million
Previous $1.41 Million 1.42%
% of portfolio
0.38%
Previous 0.39%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $43,239 - $53,761
56 Added 3.6%
1,613 $1.43 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $150,772 - $189,080
-208 Reduced 11.78%
1,557 $1.41 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $715,969 - $957,866
1,209 Added 217.45%
1,765 $1.37 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $15,755 - $18,573
-30 Reduced 5.12%
556 $324,000
Q3 2023

Oct 31, 2023

BUY
$434.7 - $599.3 $254,734 - $351,189
586 New
586 $314,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Manhattan West Asset Management, LLC Portfolio

Follow Manhattan West Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manhattan West Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manhattan West Asset Management, LLC with notifications on news.